226 related articles for article (PubMed ID: 20808778)
21. Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina.
Hickey DG; Edwards TL; Barnard AR; Singh MS; de Silva SR; McClements ME; Flannery JG; Hankins MW; MacLaren RE
Gene Ther; 2017 Dec; 24(12):787-800. PubMed ID: 28872643
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
23. Distinct Expression Patterns of AAV8 Vectors with Broadly Active Promoters from Subretinal Injections of Neonatal Mouse Eyes at Two Different Ages.
Xiong W; Cepko C
Adv Exp Med Biol; 2016; 854():501-7. PubMed ID: 26427452
[TBL] [Abstract][Full Text] [Related]
24. Abnormal reactivity of muller cells after retinal detachment in mice deficient in GFAP and vimentin.
Verardo MR; Lewis GP; Takeda M; Linberg KA; Byun J; Luna G; Wilhelmsson U; Pekny M; Chen DF; Fisher SK
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3659-65. PubMed ID: 18469190
[TBL] [Abstract][Full Text] [Related]
25. alpha2-Macroglobulin induces glial fibrillary acidic protein expression mediated by low-density lipoprotein receptor-related protein 1 in Müller cells.
Barcelona PF; Ortiz SG; Chiabrando GA; Sánchez MC
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):778-86. PubMed ID: 20881288
[TBL] [Abstract][Full Text] [Related]
26. Targeted expression of two proteins in neural retina using self-inactivating, insulated lentiviral vectors carrying two internal independent promoters.
Semple-Rowland SL; Eccles KS; Humberstone EJ
Mol Vis; 2007 Oct; 13():2001-11. PubMed ID: 17982424
[TBL] [Abstract][Full Text] [Related]
27. Peptidyl arginine deiminase 4 deficiency protects against subretinal fibrosis by inhibiting Müller glial hypercitrullination.
Palko SI; Saba NJ; Bargagna-Mohan P; Mohan R
J Neurosci Res; 2023 Apr; 101(4):464-479. PubMed ID: 36579746
[TBL] [Abstract][Full Text] [Related]
28. Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in
Boon N; Alves CH; Mulder AA; Andriessen CA; Buck TM; Quinn PMJ; Vos RM; Koster AJ; Jost CR; Wijnholds J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808129
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of glial fibrillary acidic protein in Müller radial glia during retinal degeneration.
Ekström P; Sanyal S; Narfström K; Chader GJ; van Veen T
Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1363-71. PubMed ID: 3417421
[TBL] [Abstract][Full Text] [Related]
30. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice.
Gholizadeh S; Tharmalingam S; Macaldaz ME; Hampson DR
Hum Gene Ther Methods; 2013 Aug; 24(4):205-13. PubMed ID: 23808551
[TBL] [Abstract][Full Text] [Related]
31. A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.
Biswal MR; Prentice HM; Dorey CK; Blanks JC
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8044-53. PubMed ID: 25377223
[TBL] [Abstract][Full Text] [Related]
32. A Novel Method Combining Vitreous Aspiration and Intravitreal AAV2/8 Injection Results in Retina-Wide Transduction in Adult Mice.
Da Costa R; Röger C; Segelken J; Barben M; Grimm C; Neidhardt J
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5326-5334. PubMed ID: 27784063
[TBL] [Abstract][Full Text] [Related]
33. Citrullination of glial intermediate filaments is an early response in retinal injury.
Wizeman JW; Nicholas AP; Ishigami A; Mohan R
Mol Vis; 2016; 22():1137-1155. PubMed ID: 27703308
[TBL] [Abstract][Full Text] [Related]
34. Laser photocoagulation enhances adeno-associated viral vector transduction of mouse retina.
Lee SH; Colosi P; Lee H; Ohn YH; Kim SW; Kwak HW; Park TK
Hum Gene Ther Methods; 2014 Feb; 25(1):83-91. PubMed ID: 24191872
[TBL] [Abstract][Full Text] [Related]
35. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S
Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327
[TBL] [Abstract][Full Text] [Related]
36. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of a glial fibrillary acidic protein-LacZ transgene in retinal astrocytes and Müller cells.
Verderber L; Johnson W; Mucke L; Sarthy V
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1137-43. PubMed ID: 7730023
[TBL] [Abstract][Full Text] [Related]
38. Adenovector-mediated hair cell regeneration is affected by promoter type.
Praetorius M; Hsu C; Baker K; Brough DE; Plinkert P; Staecker H
Acta Otolaryngol; 2010 Feb; 130(2):215-22. PubMed ID: 20095092
[TBL] [Abstract][Full Text] [Related]
39. Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2.
Cehajic-Kapetanovic J; Le Goff MM; Allen A; Lucas RJ; Bishop PN
Mol Vis; 2011; 17():1771-83. PubMed ID: 21750604
[TBL] [Abstract][Full Text] [Related]
40. Glial promoter selectivity following AAV-delivery to the immature brain.
von Jonquieres G; Mersmann N; Klugmann CB; Harasta AE; Lutz B; Teahan O; Housley GD; Fröhlich D; Krämer-Albers EM; Klugmann M
PLoS One; 2013; 8(6):e65646. PubMed ID: 23799030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
